Mortality due to Colon and Rectal Cancer in Brazil and its Regions between 2006 and 2020

• Autor(a) principal: Tofani, Andrea Almeida
• Data de Publicação: 2024
• Outros Autores: Verly-Miguel, Marcus Vinícius Barbosa, Marques, Marcio Candeias, de Almeida, Marina Rodrigues, Rezende, Patricia Moreira dos Santos Menezes, da Nobrega, Viviane Azevedo, Cunha, Lysia Daniela Santos, Leite, Tatiana Henriques
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Revista Brasileira de Cancerologia (Online)
• Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/4404
• topic: Epidemiologia/estatística & dados numéricos; Neoplasias Colorretais; Estudos de Séries Temporais; Brasil; Epidemiology/statistics & numerical data; Colorectal Neoplasms; Time Series Studies; Brazil; Epidemiología/estadística & datos numéricos; Neoplasias Colorrectales

Introduction: In Brazil, 704 thousand new cases of cancer were estimated for each year of the triennium 2023-2025, and colon and rectal cancer (CRC) is the type of neoplasm responsible for the third highest mortality rate for both sexes in the country. Objective: To analyze the temporal trend of premature mortality by CRC from 2006 to 2020, for both sexes, in Brazil and its five macroregions, and to evaluate whether the goal proposed by the Strategic Action Plan for Tackling Chronic non Communicable Diseases in Brazil 2011-2022 of the Ministry of Health (MH) in relation to CCR has been met. Method: Time series study of standardized premature mortality rates by CRC (ICD-10: C18-21); the study population is Brazil’s population obtained from DATASUS’ Mortality Information System from 2006 to 2020. Results: Premature mortality rates by CRC in Brazil and in all five macroregions increased linearly over the period investigated, but with important regional differences. The target proposed by the MH’s Plan for CRC was not met. Conclusion: There was an increase in premature mortality rates by CRC in Brazil, a trend expected for developing countries. As it is a type of cancer that involves modifiable risk factors, continuous actions to manage these factors are important, such as national health promotion policies. Furthermore, studies are needed to support preventive policies for screening and early diagnosis programs.